Key result
Discontinuation of methimazole for five days in a patient with advanced heart failure and Graves' disease led to severe QTc prolongation (607 ms) and subsequent ventricular fibrillation.
Why the study?
Ventricular fibrillation secondary to thyrotoxicosis is rarely reported and data on its underlying mechanism remain scarce.
Case Report (n=1)
No
Discontinuation of antithyroid medications prior to radioiodine ablation in patients with advanced heart failure can lead to severe QTc prolongation and potentially lethal ventricular arrhythmias.
Highlights arrhythmia risk with antithyroid cessation before ablation in advanced HF; hypothesis-generating for safer periprocedural protocols.
The following case involves a 62-year-old female patient suffering from heart failure with reduced ejection fraction (HFrEF) secondary to non-ischemic cardiomyopathy and Graves disease, who developed ventricular fibrillation (VF) after discontinuation of methimazole in preparation for radioiodine ablation. Electrocardiogram (ECG) showed a severely prolonged QTc in the setting of thyrotoxicosis, which significantly improved with high dose methimazole. VF secondary to thyrotoxicosis has rarely been reported and the literature review shows scarce data on its mechanism. Our case demonstrates not only a possible mechanism for the arrhythmia, but also highlights a potential risk factor for it. The report details how discontinuing antithyroid medication leads to VF in our patient and reviews the current literature on antithyroid withdrawal prior to radioiodine ablation therapy. Caution should be taken when discontinuing antithyroid medications in patients with advanced heart failure as potentially lethal ventricular arrhythmias can ensue.
No takes yet. Share an insight, caveat, or question.
Sikandar et al. (2021) conducted a case report in Heart failure with reduced ejection fraction and Graves' disease (n=1). Discontinuation of methimazole was evaluated on Development of ventricular fibrillation and QTc prolongation. Discontinuation of methimazole for five days in a patient with advanced heart failure and Graves' disease led to severe QTc prolongation (607 ms) and subsequent ventricular fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: